Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection
- PMID: 15516635
Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection
Abstract
The Th1 response elicited in mice infected with Leishmania major has been used as a model to characterize cellular immune defects associated with L. amazonensis infection. However, it is not known if the immune response associated with the infection by virulent L. major parasites can promote resistance to a subsequent L. amazonensis infection. Our data demonstrate that C3HeB/FeJ mice infected subcutaneously with virulent L. major are resistant to an L. amazonensis challenge. The healing phenotype is characterized by a Th1 response as measured by increased production of interferon-gamma and low levels of interleukin-4 in the draining lymph node. Together, this indicates that the Th1 response associated with L. major infection can promote resistance to L. amazonensis infection and that it can be used as a tool to study the immune defects associated with L. amazonensis infection.
Similar articles
-
Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.Immunol Lett. 2006 May 15;105(1):38-47. doi: 10.1016/j.imlet.2005.12.002. Epub 2006 Jan 13. Immunol Lett. 2006. PMID: 16466810
-
Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.Exp Parasitol. 1997 Sep;87(1):47-57. doi: 10.1006/expr.1997.4183. Exp Parasitol. 1997. PMID: 9287957
-
Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.Cell Immunol. 2006 Aug;242(2):61-71. doi: 10.1016/j.cellimm.2006.09.006. Epub 2006 Nov 21. Cell Immunol. 2006. PMID: 17118349
-
Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.Parasite Immunol. 2009 Aug;31(8):423-31. doi: 10.1111/j.1365-3024.2009.01116.x. Parasite Immunol. 2009. PMID: 19646206 Review.
-
Immunological factors governing resistance and susceptibility of mice to Leishmania major infection.Rev Latinoam Microbiol. 2001 Jul-Sep;43(3):135-42. Rev Latinoam Microbiol. 2001. PMID: 17061500 Review.
Cited by
-
Characterization of the B cell response to Leishmania infection after anti-CD20 B cell depletion.Int J Clin Exp Pathol. 2015 Jun 1;8(6):6192-202. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261496 Free PMC article.
-
Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection.Int J Parasitol. 2008 Mar;38(3-4):417-29. doi: 10.1016/j.ijpara.2007.08.010. Epub 2007 Sep 20. Int J Parasitol. 2008. PMID: 17959178 Free PMC article.
-
A deficiency in the B cell response of C57BL/6 mice correlates with loss of macrophage-mediated killing of Leishmania amazonensis.Int J Parasitol. 2010 Feb;40(2):157-61. doi: 10.1016/j.ijpara.2009.11.010. Epub 2009 Dec 11. Int J Parasitol. 2010. PMID: 20004204 Free PMC article.
-
An in vitro model of antibody-enhanced killing of the intracellular parasite Leishmania amazonensis.PLoS One. 2014 Sep 5;9(9):e106426. doi: 10.1371/journal.pone.0106426. eCollection 2014. PLoS One. 2014. PMID: 25191842 Free PMC article.
-
The magnitude of CD4(+) T-cell activation rather than TCR diversity determines the outcome of Leishmania infection in mice.Parasite Immunol. 2011 Mar;33(3):170-80. doi: 10.1111/j.1365-3024.2010.01268.x. Parasite Immunol. 2011. PMID: 21306400 Free PMC article.